| Hypertension |
1 |
1 |
| Antihypertensive Agents |
0 |
0.99 |
| Cardiometabolic Risk Factors |
0 |
0.55 |
| Diuretics |
0 |
0.54 |
| ACE Inhibitor |
0 |
0.49 |
| Cardiovascular Risk Management |
0 |
0.45 |
| Arrhythmia |
0 |
0.36 |
| Coronary Artery Disease (CAD) |
0 |
0.34 |
| Coronary Heart Disease Risk Factors |
0 |
0.34 |
| Heart Failure (HF) |
0 |
0.33 |
| Cerebrovascular Accident |
0 |
0.32 |
| Heart |
0 |
0.24 |
| Calcium Channel Blockers |
0 |
0.21 |
| Calcium |
0 |
0.15 |
| Myocardial Infarction (MI) |
0 |
0.14 |
| Osteoarthritis |
0 |
0.14 |
| End-Stage Renal Disease |
0 |
0.12 |
| Renal Disease |
0 |
0.12 |
| Blood |
0 |
0.1 |
| Cardiovascular disease |
0 |
0.1 |
| Revenue and Practice Management |
0 |
0.08 |
| Renal Cell Carcinoma |
0 |
0.06 |